Transparency Market Research has compiled a vast database on the global pharmaceutical industry. One of the market intelligence reports is based on the technologies in the field of ribonucleic acid interference. The report, titled “RNAI Technology Market - Global Forecast, Share, Size, Growth And Industry Analysis (2010-2017),” documents the milestones generated in this market, before moving on to give an accurate analysis of its future.
Gene regulation has been a major area of study for many decades, of which the global RNAi technologies market is a relatively new part. It has become a crucial method of studying gene regulation and gene expression.
The global RNAi technologies market could possibly show a double-digit growth rate in the coming years. It is even being considered as a modern replacement for recombinant DNA and other technologies from the post-genomic era that are still being used today.
The global RNAi technologies market is currently being driven by the large number of opportunities that it can gain in application fields such as medical research, drug discovery, therapeutics, and agriculture. RNAi technologies can be especially useful in studies on functional genomics and metabolism.
In terms of therapeutic application, the global RNAi technologies market is segmented into metabolic disorders, cardiology, ophthalmology, oncology, and neurology. In terms of products and tools used for RNAI applications, this market is segmented into vectors, software, and libraries. In terms of types, the global RNAI technologies market is segmented into micro RNAi and small interfering RNAi.
The global RNAi technologies market is segmented from a geographical perspective into Europe, North America, Asia Pacific, and the Rest of the World.
A significant number of players in the global RNAi technologies market are supported by venture capitalists and investors, especially in the field of oligonucleotide drug development and the role of RNAi technologies in it. For the sake of better understanding, the market itself can be viewed from two different perspectives: research and development efforts and the string of mergers and acquisitions. The global RNAi technologies market report comprises an elaborate timeline of takeovers and mergers that will be instrumental in deciding the future of this market.
The global RNAi technologies market is currently being shaped by specialty companies. At the same time, the market is also a large part of the plans of big pharma companies, which are looking to strengthen their outlooks by adding RNAi developments to their pipeline. The global RNAi technologies market is therefore becoming a positively lucrative avenue for companies as well as investors for the near future.
The key players in the global RNAi technologies market are Invitrogen, Qiagen, and Ambion.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.